ObjectiveTo evaluate the efficacy of management of patients with chronic heart failure by family physician, who followed Chinese Guidelines for the Diagnosis and Treatment of Heart Failure.
MethodsA total of 51 patients with chronic heart failure visiting Shanghai Hongkou District Liangcheng New Village Community Health Service Center from September 2016 to September 2017 were investigated.All the patients were randomly divided into two groups:management group (n=26) and control group (n=25).In the management group, the patients received follow-up, health education and exercise diet guidance by family physicians.They took RAAS antagonist and β-blocker, gradually increasing the dosage until the target dose was reached.In the control group, the patients received regular outpatient follow-up.NT-proBNP, LVEF, quality of life score of patients in the two groups before and after treatment were compared in the study.
ResultsNo significant differences were observed between the two groups at baseline.But significant differences were found between the two groups after 12-month follow-up (management group vs.control group):NT-proBNP (717.15±196.78)pg/mL vs.(851.88±182.33)pg/mL, P < 0.05; quality of life score SF-36, (82.54±7.00 vs. 78.08±5.92, P < 0.05), MLHFQ(40.50±6.35 vs. 44.00±5.42, P < 0.05).
ConclusionCombination of evidence-based medicine and family physician mode management for patients with chronic heart failure is feasible and effective.